FISCAL NOTE
Date Requested: February 09, 2026
Time Requested: 04:44 PM |
| Agency: |
Insurance Commission |
|---|
| CBD Number: |
Version: |
Bill Number: |
Resolution Number: |
| 4032 |
Introduced |
SB884 |
|
|---|
| CBD Subject: |
Insurance |
|---|
|
FUND(S):
7152
Sources of Revenue:
Special Fund
Legislation creates:
Fiscal Note Summary
Effect this measure will have on costs and revenues of state government.
Senate Bill 884, if enacted, requires coverage of treatment for certain pediatric autoimmune neuropsychiatric disorders in certain circumstances.
SB884 would have no fiscal impact on the WV Offices of the Insurance Commissioner.
See Memorandum Summary for more information.
Fiscal Note Detail
| Effect of Proposal |
Fiscal Year |
2026
Increase/Decrease
(use"-") |
2027
Increase/Decrease
(use"-") |
Fiscal Year
(Upon Full
Implementation) |
| 1. Estmated Total Cost |
0 |
0 |
0 |
| Personal Services |
0 |
0 |
0 |
| Current Expenses |
0 |
0 |
0 |
| Repairs and Alterations |
0 |
0 |
0 |
| Assets |
0 |
0 |
0 |
| Other |
0 |
0 |
0 |
| 2. Estimated Total Revenues |
0 |
0 |
0 |
Explanation of above estimates (including long-range effect):
Please explain increases and decreases in personal services, current expenses, repairs and alterations, assets, other costs and revenues, including assumptions and data sources and delineation between start-up and ongoing costs. Please also include a long-range schedule of costs and revenues if fiscal impact is expected to vary in future years.
Memorandum
Senate Bill 884, if enacted, requires coverage treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections; requires coverage for treatment of pediatric acute onset neuropsychiatric syndrome; requires a prior authorization to be obtained; and requires that a physician demonstrate that all other treatments have been exhausted.
SB884 may impact insurance premium rates in the private market.
There is no fiscal impact to the WV Offices of the Insurance Commissioner.
It should be noted that SB884 does not contain language limiting the insurance benefits provided under the proposed bill to the essential health benefits (EHB) specified under section 130(b) of the Patient Protection and Affordable Care Act (PPACA). PPACA1311 (d)(3) provides that a state must defray the cost by direct payment to enrollees or to the Plan of any state mandated benefit in excess of the EHB. To the extent that the health insurance benefits required by SB884 do not fall within the EHB, a potential cost to the State exists.
As this bill amends their respective Code sections, it is recommended that PEIA and BMS be consulted regarding the fiscal impact on their programs.
Person submitting Fiscal Note: Juanita Wimmer
Email Address: juanita.d.wimmer@wv.gov